TAZACT 4.5 GM

About

Piperacillin/Tazobactam is a broad-spectrum antibiotic combination consisting of a penicillin-class beta-lactam antibiotic, piperacillin, and a beta-lactamase inhibitor, tazobactam. Piperacillin exerts its bactericidal action by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins (PBPs), leading to cell lysis and death. Tazobactam, on the other hand, protects piperacillin from degradation by many bacterial beta-lactamase enzymes, which are often responsible for antibiotic resistance. This combination significantly extends piperacillin's spectrum of activity to include many beta-lactamase-producing Gram-positive, Gram-negative, and anaerobic bacteria. It is a critical agent for treating severe and complicated infections, particularly in hospital settings, where multi-drug resistant pathogens are a concern.

Uses

• Nosocomial pneumonia
• Complicated intra-abdominal infections
• Complicated skin and skin structure infections
• Pelvic inflammatory disease

Directions For Use

Administer intravenously as a slow infusion over 30 minutes, as directed by a healthcare professional.

Benefits

• Broad-spectrum antibacterial activity.
• Effective against resistant bacteria (beta-lactamase producers).
• Covers Gram-positive, Gram-negative, and anaerobes.
• Crucial for severe hospital-acquired infections.
• Reduces treatment failures in complex cases.
• Well-established efficacy in critical care.

Side Effects

• Diarrhea
• Nausea
• Vomiting
• Rash
• Headache
• Insomnia
• Constipation
• Fever
• Injection site reactions
• Hypersensitivity reactions (anaphylaxis)
• Thrombocytopenia
• Leukopenia

Safety Measures

• Alcohol - No direct interaction, but alcohol may exacerbate gastrointestinal side effects.
• Pregnancy - Use only if clearly needed; animal studies show no evidence of harm, but human data are limited.
• Breastfeeding - Use with caution; small amounts are excreted in breast milk, potentially causing diarrhea or rash in infant.
• Liver - Use with caution in severe hepatic impairment; monitor liver function tests.
• Kidney - Dose adjustment is required in patients with renal impairment; monitor kidney function closely.
• Lung - Generally safe; no specific lung-related safety concerns, but monitor for hypersensitivity reactions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.